Purpose

This purpose of this test is for the simultaneous qualitative detection and identification of multiple respiratory viral and bacterial nucleic acids, including nucleic acids from SARS-CoV-2, in nasopharyngeal swabs obtained from individuals suspected of respiratory tract infections. Identification of specific viral and bacterial nucleic acids from individuals exhibiting signs and/or symptoms of respiratory infection is indicative of the presence of the identified microorganism and aids in the diagnosis of respiratory infection if used in conjunction with other clinical and epidemiological information. The results of this test should not be used as the sole basis for diagnosis, treatment, or other patient management decisions.

Collect

Nasopharyngeal swabs in universal viral transport media
Red cap ESWAB Flexible minitip flocked swabs

Storage/Transport Temperature

Transport at room temperature immediately after collection

Stability (from collection to initiation)

Room temperature: 4 hours
Refrigerated: 3 days

Cerner Orderable(s)

Respiratory Panel incl. COVID PCR

Performed

Sun-Sat

Ordering Recommendations

Follow current COVID and Flu testing algorithms for specific patient populations.

COVID and Flu testing algorithm

Methodology

Qualitative PCR FilmArray

Synonyms

  • Upper respiratory infection
  • Viral respiratory infection

Reference Interval

Negative

Interpretive Data

The test assesses the presence of mutliple respiratory pathogens to help streamline  antimicrobial treatment.

Influenza A and B
RSV A and B (Respiratory Syncytial Virus)
Parainfluenza 1-4
Metapneumovirus
Rhinovirus/Enterovirus
Adenovirus
Coronavirus
Chlamydophila penumoniae
Mycoplasma pneumoniae
Bordetella pertussis/parapertussis


 

CPT Codes

87486, 87581, 87633, 87798
Collection

Purpose

This purpose of this test is for the simultaneous qualitative detection and identification of multiple respiratory viral and bacterial nucleic acids, including nucleic acids from SARS-CoV-2, in nasopharyngeal swabs obtained from individuals suspected of respiratory tract infections. Identification of specific viral and bacterial nucleic acids from individuals exhibiting signs and/or symptoms of respiratory infection is indicative of the presence of the identified microorganism and aids in the diagnosis of respiratory infection if used in conjunction with other clinical and epidemiological information. The results of this test should not be used as the sole basis for diagnosis, treatment, or other patient management decisions.

Collect

Nasopharyngeal swabs in universal viral transport media
Red cap ESWAB Flexible minitip flocked swabs

Storage/Transport Temperature

Transport at room temperature immediately after collection

Stability (from collection to initiation)

Room temperature: 4 hours
Refrigerated: 3 days
Ordering

Cerner Orderable(s)

Respiratory Panel incl. COVID PCR

Performed

Sun-Sat

Ordering Recommendations

Follow current COVID and Flu testing algorithms for specific patient populations.

COVID and Flu testing algorithm

Methodology

Qualitative PCR FilmArray

Synonyms

  • Upper respiratory infection
  • Viral respiratory infection
Result Interpretation

Reference Interval

Negative

Interpretive Data

The test assesses the presence of mutliple respiratory pathogens to help streamline  antimicrobial treatment.

Influenza A and B
RSV A and B (Respiratory Syncytial Virus)
Parainfluenza 1-4
Metapneumovirus
Rhinovirus/Enterovirus
Adenovirus
Coronavirus
Chlamydophila penumoniae
Mycoplasma pneumoniae
Bordetella pertussis/parapertussis


 
Administrative

CPT Codes

87486, 87581, 87633, 87798